[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350186-105":59,"doc-detail-350186-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epiplakin-expression-in-non-melanoma-skin-cancer-associations-with-epithelial-mesenchymal-transition-markers-and-tumor-invasion","Epiplakin Expression in Non-Melanoma Skin Cancer - Associations with Epithelial-Mesenchymal Transition Markers and Tumor Invasion","","Epiplakin, a cytoskeletal plakin-family protein, remains poorly understood in skin cancers. This retrospective study evaluated epiplakin expression in squamous cell carcinomas, basal cell carcinomas, and benign intradermal nevi, and examined links with epithelial-mesenchymal transition (EMT) markers and tumor progression. Immunohistochemistry quantified epiplakin, E-cadherin, and N-cadherin; correlations were tested against cadherin levels and Breslow thickness.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epiplakin-expression-in-non-melanoma-skin-cancer-associations-with-epithelial-mesenchymal-transition-markers-and-tumor-invasion/350186/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epiplakin-expression-in-non-melanoma-skin-cancer-associations-with-epithelial-mesenchymal-transition-markers-and-tumor-invasion/350186.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this study on epiplakin in skin cancer?","Question",{"text":112,"@type":113},"To evaluate epiplakin expression in cutaneous skin lesions and determine whether it is associated with epithelial-mesenchymal transition markers and tumor progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which lesion types were included in the retrospective analysis?",{"text":117,"@type":113},"Squamous cell carcinomas, basal cell carcinomas, and benign intradermal nevi collected between 2021 and 2025.",{"name":119,"@type":110,"acceptedAnswer":120},"How does epiplakin expression relate to EMT markers in non-melanoma skin cancers?",{"text":121,"@type":113},"Epiplakin shows a strong positive correlation with E-cadherin and a weak positive correlation with N-cadherin, with no significant correlation reported for Breslow thickness.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350186,1790095098,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ORIGINAL ARTICLE  \nEpiplakin expression in non-melanoma skin cancer: associations with epithelial-mesenchymal transition markers and tumor invasion􀀂  \nDamla Gül Fındık  a,∗ , Özlem Türelikb  \na Department of Histology and Embryology, Faculty of Medicine, Balıkesir University, Balıkesir, Turkey b Department of Pathology, Faculty of Medicine, Bilecik S¸eyh Edebali University, Bilecik, Turkey  \nReceived 15 December 2025; accepted 2 February 2026  \nKEYWORDS  \nBasal cell carcinoma; Epithelialmesenchymal transition;  \nPlakins;  \nSkin neoplasms; Squamous cell carcinoma  \nAbstract  \nBackground/Objectives: Epiplakin is a member of the plakin family of proteins involved in cytoskeletal organization, yet its role in skin cancers remains poorly understood. This study aimed to evaluate epiplakin expression in cutaneous skin lesions and to investigate its association with epithelial-mesenchymal transition markers and tumor progression.  \nMethods: The authors retrospectively analyzed skin specimens from squamous cell carcinomas, basal cell carcinomas, and benign intradermal nevi collected between 2021 and 2025. Histopathological features were assessed, and immunohistochemical analysis of Epiplakin, Ecadherin, and N-cadherin was performed. Epiplakin expression was quantiﬁed and correlated with cadherin levels and Breslow thickness. Plakin family protein-protein interaction networks were analyzed using KEGG pathway and GO functional enrichment.  \nResults: Protein-protein interaction network analysis demonstrated that plakin family members are associated with multiple cancer-related pathways, with a prominent enrichment in regulating cell proliferation. Epiplakin expression was signiﬁcantly higher in squamous cell carcinomas (389.94 ± 70.56) compared with basal cell carcinomas (70.39 ± 15.32) and intradermal nevi, while basal cell carcinomas showed a signiﬁcant decrease compared with normal skin (p \u003C 0.05) . In non-melanoma skin cancers, epiplakin expression demonstrated a strong positive correlation with E-cadherin (r= 0.565, p \u003C 0.001) and a weak positive correlation with N-cadherin (r= 0.329, p \u003C 0.05) . No signiﬁcant correlation was observed with Breslow thickness (p > 0.05) . Study limitations: Retrospective design and the absence of high-grade squamous cell carcinoma cases in the study population.  \n􀀂 Study conducted at the Bilecik S¸eyh Edebali University Faculty of Medicine and Bilecik Training and Research Hospital, Bilecik, Turkey.  \n∗ Corresponding author.  \nE-mail: damla.ﬁ[ndik@balikesir.edu.tr](ndik@balikesir.edu.tr) (D.G. Fındık).  \n[https://doi.org/10.1016/j.abd.2026.501350](https://doi.org/10.1016/j.abd.2026.501350)  \n0365-0596/© 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espaa, S.L.U. This is an open access article under the CC BY license ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)).  \nConclusions: This is the ﬁrst study to assess epiplakin expression among epithelial cutaneous cancers. Epiplakin appears to be associated with epithelial---mesenchymal transition and early tumor progression, and its differential expression pattern may provide diagnostic utility.© 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espaa, S.L.U. This is an open access article under the CC BY license ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/) ).  \nIntroduction  \nCarcinogenesis is a complex biological process involving cellular proliferation, invasion, and alterations in adhesion, with the cytoskeleton playing a pivotal role in maintaining cell shape, polarity, and mechanical stability. Among the proteins that anchor cytoskeletal elements --- such as microﬁlaments, intermediate ﬁlaments, and microtubules--- to cell junctions, the plakin family has emerged as essential for both tissue integrity and tumor biology. Members of this family, including Desmoplakin (DSP), Envoplakin (EVPL), Periplakin (PPL), Plectin (PLEC), and","cbCaip6zbQ21ZU9G","https://ap.wps.com/l/cbCaip6zbQ21ZU9G","pdf",6743943,14,"English","# Abstract\n## Background/Objectives\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main purpose of this study on epiplakin in skin cancer?\",\"answer\":\"To evaluate epiplakin expression in cutaneous skin lesions and determine whether it is associated with epithelial-mesenchymal transition markers and tumor progression.\"},{\"question\":\"Which lesion types were included in the retrospective analysis?\",\"answer\":\"Squamous cell carcinomas, basal cell carcinomas, and benign intradermal nevi collected between 2021 and 2025.\"},{\"question\":\"How does epiplakin expression relate to EMT markers in non-melanoma skin cancers?\",\"answer\":\"Epiplakin shows a strong positive correlation with E-cadherin and a weak positive correlation with N-cadherin, with no significant correlation reported for Breslow thickness.\"}]","Epiplakin Expression in Non-Melanoma Skin Cancer - Associations with Epithelial-Mesenchymal Transition Markers and Tumor Invasion | PDF",1790087589,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abb900e4414babd81ac593279cc6951c.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57f75f87947005b997a3ba05b0ecd876.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c43e57b2a280f72867382c74f0d5b2f6.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30b627085894351be63efa133c22faf5.webp",980,1306]